Status:
COMPLETED
Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Centre Imagerie Cellulaire Santé, Faculté Médecine et Pharmacie, CLERMONT FERRAND
Conditions:
Ovarian Cysts
Endometriosis
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
To evaluate the feasibility of using Indocyanine Green in the laparoscopic surgical treatment of benign organic ovarian cysts (dermoid, serous, mucinous and endometriotic) in patients with a short-ter...
Detailed Description
The study will be open to any patient meeting the inclusion / exclusion criteria, scheduled for intraperitoneal cystectomy or cyst destruction using Plasmajet, corresponding to a benign organic cyst r...
Eligibility Criteria
Inclusion
- An adult woman of childbearing potential who has a desire for short-term pregnancy, under the age of 42, to undergo laparoscopic accessible surgical treatment (\<10 cm) for a benign organic ovarian cyst (serous, mucinous, dermoid or endometriotic) whose diagnosis was made on imaging (ultrasound or MRI).
- Patient able to provide informed consent to her participation in the study.
- Patient covered by the " Sécurité Social " insurance system.
Exclusion
- Adult patient under protection, tutorship or curatorship.
- Refusal of the patient or poor understanding of the French language.
- Known allergy to iodine.
- Current pregnancy or breastfeeding
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04355312
Start Date
June 15 2020
End Date
December 12 2022
Last Update
January 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000